コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 nit mutation, G32R, has been associated with childhood absence epilepsy.
2 lamotrigine in children with newly diagnosed childhood absence epilepsy.
3 fective than lamotrigine in the treatment of childhood absence epilepsy.
4 .2 channels were discovered in patients with childhood absence epilepsy.
5 s relatively mild epilepsy syndromes such as childhood absence epilepsy.
8 le myoclonic epilepsy, 10 patients each with childhood absence epilepsy and juvenile absence epilepsy
9 s in the I-II loop (the region in which most childhood absence epilepsy-associated mutations are foun
11 orders, including myoclonic atonic epilepsy, childhood absence epilepsy, autism, and intellectual dis
13 than 30 mutations apparently predisposing to childhood absence epilepsy (CAE) and other idiopathic ge
17 e that may contribute to the pathogenesis of childhood absence epilepsy (CAE), but the molecular basi
18 ed with genetic epilepsy syndromes including childhood absence epilepsy (CAE), juvenile myoclonic epi
23 our groups: (i) classic JME (72%), (ii) CAE (childhood absence epilepsy) evolving to JME (18%), (iii)
24 clonic epilepsy, one out of 10 patients with childhood absence epilepsy, four out of 10 patients with
25 d with genetic epilepsy syndromes, including childhood absence epilepsy, generalized epilepsy with fe
26 ed with several epilepsy syndromes including childhood absence epilepsy, generalized tonic clonic sei
29 f thalamic reticular nucleus-enriched, human childhood absence epilepsy-linked gene Cacna1h in iKOp/q
30 autosomal dominant mutation associated with childhood absence epilepsy that generates a PTC in exon